Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neisseria meningitidis | 5 | 2021 | 16 | 2.290 |
Why?
|
| Meningococcal Vaccines | 2 | 2021 | 7 | 1.280 |
Why?
|
| Nanocomposites | 1 | 2021 | 19 | 0.790 |
Why?
|
| Chitosan | 1 | 2021 | 36 | 0.780 |
Why?
|
| Hydrogels | 1 | 2021 | 37 | 0.770 |
Why?
|
| Polysaccharides | 2 | 2018 | 58 | 0.770 |
Why?
|
| Bacterial Capsules | 3 | 2018 | 6 | 0.700 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 202 | 0.680 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2018 | 23 | 0.650 |
Why?
|
| Copper | 1 | 2018 | 105 | 0.590 |
Why?
|
| Lead | 1 | 2018 | 93 | 0.580 |
Why?
|
| Sialic Acids | 2 | 2013 | 3 | 0.490 |
Why?
|
| Tetanus Toxin | 1 | 2013 | 3 | 0.460 |
Why?
|
| Vaccines, Conjugate | 1 | 2013 | 7 | 0.460 |
Why?
|
| Peptide Fragments | 1 | 2013 | 308 | 0.390 |
Why?
|
| Transferases | 1 | 2021 | 12 | 0.200 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 76 | 0.190 |
Why?
|
| Drug Carriers | 1 | 2021 | 125 | 0.180 |
Why?
|
| Career Mobility | 1 | 2020 | 24 | 0.180 |
Why?
|
| Women | 1 | 2020 | 27 | 0.180 |
Why?
|
| Kinetics | 1 | 2021 | 708 | 0.180 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 68 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 76 | 0.160 |
Why?
|
| Nucleotides | 1 | 2018 | 36 | 0.160 |
Why?
|
| Biodegradation, Environmental | 1 | 2018 | 80 | 0.160 |
Why?
|
| Rhenium | 1 | 2017 | 12 | 0.150 |
Why?
|
| Coordination Complexes | 1 | 2017 | 28 | 0.150 |
Why?
|
| Organometallic Compounds | 1 | 2017 | 73 | 0.150 |
Why?
|
| Universities | 1 | 2020 | 442 | 0.140 |
Why?
|
| Meningitis, Meningococcal | 1 | 2013 | 3 | 0.120 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2013 | 6 | 0.120 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 1180 | 0.120 |
Why?
|
| Campylobacter jejuni | 1 | 2013 | 22 | 0.110 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 1568 | 0.110 |
Why?
|
| Sialyltransferases | 1 | 2011 | 1 | 0.100 |
Why?
|
| Neisseria meningitidis, Serogroup C | 1 | 2011 | 1 | 0.100 |
Why?
|
| Animals | 2 | 2021 | 15081 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 144 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 168 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 803 | 0.090 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2011 | 149 | 0.090 |
Why?
|
| Humans | 4 | 2021 | 37093 | 0.060 |
Why?
|
| Mice | 1 | 2013 | 5913 | 0.050 |
Why?
|
| Teaching | 1 | 2020 | 55 | 0.040 |
Why?
|
| Research | 1 | 2020 | 163 | 0.040 |
Why?
|
| Serotyping | 1 | 2013 | 36 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 325 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2013 | 132 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 444 | 0.030 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2011 | 52 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2013 | 453 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2011 | 109 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 188 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 674 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 364 | 0.020 |
Why?
|
| Female | 2 | 2020 | 20969 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 515 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 1095 | 0.020 |
Why?
|